Data were analyzed based on three criteria: acute administration (injection 1), repeated administration (injections 1, 3, and 8), and post-treatment effects (days 1 and 3 post-treatment)
Immunofluorescence analysis Tissue sections were placed on poly-L-lysine-coated slides, deparaffinized and dehydrated for immunofluorescence analysis
Es lo mejor que hay, declar a The New York Times la doctora Katherine Tuttle, catedrtica de medicina de la Facultad de Medicina de la Universidad de Washington y autora del estudio
In the STEP UP trial, adults living with obesity who received semaglutide 7.2mg achieved an average weight loss of 18.7% over 72 weeks, compared with 15.6% with 2.4mg and 3.9% with placebo
FDA-approved versions like Wegovy and Zepbound have gone through rigorous review processes
The median time to discontinuation was 334.5 days (IQR 221541 days)